Atai Life Sciences N.V.
(NQ:
ATAI
)
1.420
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
26
27
Next >
Psychedelic Stock Gainers And Losers From August 16, 2022
August 16, 2022
Via
Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
August 15, 2022
Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility...
Via
Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
August 15, 2022
Via
Benzinga
Recap: ATAI Life Sciences Q2 Earnings
August 15, 2022
ATAI Life Sciences (NASDAQ:ATAI) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
August 14, 2022
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then.
Via
Talk Markets
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
August 12, 2022
Via
Benzinga
ATAI Life Sciences Earnings: A Preview
August 12, 2022
ATAI Life Sciences (NASDAQ:ATAI) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.
Via
Benzinga
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
August 11, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
August 10, 2022
Via
Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study...
Via
FinancialNewsMedia
Topics
Supply Chain
Exposures
Supply Chain
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
August 09, 2022
Via
Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
August 05, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80
Via
Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
August 04, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17
Via
Benzinga
Cathie Wood Continues Investing In Psychedelics, She Bought Over 3M Atai Shares In July Alone
August 03, 2022
Several weeks ago, Cathie Wood's ARK Fund (BATS: ARKG) invested in the biotech psychedelics sector, specifically in major player
Via
Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
August 02, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82
Via
Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
August 01, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34
Via
Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
July 30, 2022
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22
Via
Benzinga
InvestorNewsBreaks – Atai Life Sciences (NASDAQ: ATAI) Featured in Analysis Report
July 29, 2022
Via
Investor Brand Network
Topics
Derivatives
Exposures
Derivatives
Allied, Cybin Among Top Psychedelic Movers Of Today
July 28, 2022
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55
Via
Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
July 27, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06
Via
Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
July 26, 2022
GAINERS: Allied (OTC:ALID) shares closed up 22.11% at $0.55
Via
Benzinga
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
July 27, 2022
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
July 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 2.76% at $14.91 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From July 22, 2022
July 22, 2022
GAINERS: Allied (OTC:ALID) shares closed up 11.04% at $0.50
Via
Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
July 21, 2022
GAINERS: LOSERS: Allied (OTC:ALID) shares closed down 10.00% at $0.45
Via
Benzinga
Dear Psychedelic Stocks Fans, Watch This Key Catalyst
July 21, 2022
Psychedelic stocks are in focus following new legislation from both the Senate and the House that has bipartisan support.
Via
InvestorPlace
Psychedelic Stock Gainers And Losers From July 20, 2022
July 20, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 10.53% at $15.11
Via
Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
July 19, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 8.09% at $0.93
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.